Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2026 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkorAcceptable Use
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to Reports
Fundraising

Celestial AI

Celestial AI Raises $250M in Series C

Santa Clara, CAMarch 26, 20252 min read
Employees
200+

Celestial AI Raises $250M in Series C


Celestial AI has successfully raised $250M in a Series C at a $1.5B valuation led by Koch Disruptive Technologies, IAG Capital Partners.


Company Overview


Celestial AI is a AI/ML company headquartered in Santa Clara, CA, founded in 2020 with 200+ employees.


Develops optical interconnect technology platform for AI data centers


Fundraising Details


  • Amount Raised: $250M
  • Round Type: Series C
  • Valuation: $1.5B
  • Date: 2025-03-26
  • Investors: Koch Disruptive Technologies, IAG Capital Partners

About Celestial AI


Develops optical interconnect technology platform for AI data centers The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Santa Clara, CA
  • Founded: 2020
  • Team Size: 200+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in Celestial AI's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Celestial AI's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1.5B valuation marks an important milestone for Celestial AI, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, Celestial AI is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-03-26. For more information about Celestial AI, visit their headquarters at Santa Clara, CA.

Company Info

Headquarters
Santa Clara, CA
Founded
2020
Team Size
200+

Topics

Fundraising(2912)AI/ML(484)Series C(300)Celestial AI

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free